Literature DB >> 9101604

Acute renal failure due to hemolytic uremic syndrome in adult patients.

Y A Sens1, L A Miorin, H G Silva, D M Malheiros, D M Filho, P Jabur.   

Abstract

Hemolytic uremic syndrome is characterized by the simultaneous occurrence of hemolytic anemia, thrombocytopenia, and renal failure. Clinical/ pathologic data, along with the treatment and outcome of 8 adult patients with HUS, are described. There were 7 females and 1 male, age 30.7 +/- 12 years; 7 were White and 1 Black. Three patients were kidney graft recipients, 2 of whom were receiving cyclosporine; 2 patients were postpartum; 1 case followed an abortion; 1 occurred with prodromic infection; and 1 case was without a causal factor. All patients presented with hematuria and 6 with oligoanuria. Laboratory data showed hemolytic anemia with schistocytes, LDH values were 2584 +/- 2191 U/L, platelets were 79,000 +/- 40,000/mL, creatinine concentrations were 5.9 +/- 2.5 mg/dL. Renal biopsy showed thrombotic microangiopathy. Two had predominant glomerular involvement. 2 showed renal cortical necrosis, 4 were marked by predominant arteriolar involvement. In 5 patients dialytic therapy was performed. All were treated with fresh-frozen plasma infusion and 6 with plasmapheresis. Three patients died, 2 without recovery of renal function. In conclusion, the trigger events were related to renal transplant in 3.2 of them taking cyclosporine; 3 with pregnancy; 1 to precedent infection; and 1 with no causal factor. There was no correlation between histological form and outcome in this group of patients. The benefit of plasmapheresis was evident in the recovery of the extrarenal manifestations, although it did not change the renal outcome. The prognosis is poor, with a high mortality (37.5%) and/or end-stage renal failure (37.5%). Complete recovery of renal function was obtained in 25%.

Entities:  

Mesh:

Year:  1997        PMID: 9101604     DOI: 10.3109/08860229709026289

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  4 in total

1.  Elevated reticulocyte count--a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case report.

Authors:  S Serke; H Riess; H Oettle; D Huhn
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

2.  Haemolytic uraemic syndrome associated with H1N1 influenza.

Authors:  Ana Farinha; Patrícia Carrilho; Joana Felgueiras; Ana Natário; José Assunção; José Vinhas
Journal:  NDT Plus       Date:  2010-07-15

3.  Gemcitabine-associated thrombotic microangiopathy in a patient with lung cancer: A case report.

Authors:  Florence Lai-Tiong; Yann Duval; Francois Krabansky
Journal:  Oncol Lett       Date:  2017-01-05       Impact factor: 2.967

4.  Report from Mongolia -- How much do we know about the incidence of rare cases in less developed countries: a case series.

Authors:  Martin W Dünser; Otgon Bataar; Albert H Rusher; Walter R Hasibeder; Ganbat Tsenddorj
Journal:  J Med Case Rep       Date:  2008-11-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.